Tracy S. d'Entremont, MD
Medical Oncology

Tracy S. d'Entremont, MD

She/Her
Medical Oncology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Valley Forge
Penn Medicine Provider

About me

  • Director of Oncology Services, Abramson Cancer Center at Valley Forge
  • Clinical Associate Professor of Medicine (Hematology-Oncology)

My education and training

  • Pennsylvania State UniversityMedical School
  • University of Pennsylvania Health SystemResidency
  • University of Pennsylvania Health SystemFellowship

Spoken languages

English
English

Reviews

Average Rating

1124 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
September 2026
I have already recommended her.
Anonymous
September 2026
Doctor responds to messages in portal promptly, takes time to listen to all concerns during appointments, and orders imaging when necessary
Anonymous
September 2026
Knowledgeable and caring
Anonymous
September 2026
Very personable and thorough very caring and helpful

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. d'Entremont is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

d'Entremont TS, Sun W. Recent advances in colorectal cancer therapy. , Cancer Biol Ther., 2(1): 2003,6-13


d’Entremont TS, Haller DG Recent Advances in Chemotherapy for Colorectal Cancer. , Oncology Special Edition, 6: 2003,155-161


d’Entremont T, Mick R, Simbiri K, Telep R, Wray L, Acs G, Blackwood A, DeMichele A Estrogen Receptor Status Supercedes both p27 Loss and Her2/neu Overexpression as an Age-Associated Prognostic Marker in Breast Cancer. , American Society of Clinical Oncology 38th Annual Meeting: 2002


d'Entremont TS, Stevenson JP. Cancers of the large bowel and hepatobiliary tract. , Cancer Chemother Biol Response Modif., 20: 2002,435-62


Myers BS, Woolley CT, Slotter TL, Garrett WE, Best TM The influence of strain rate on the passive and stimulated engineering stress--large strain behavior of the rabbit tibialis anterior muscle. , J Biomech Eng., 120(1): 1998,126-32


Woolley CT, Best TM, Garrett WE, Slotter TL, Myers BS Stress-Strain Characterization of Muscle During Active and Passive Loading. , Orthopedic Research Society 40th Annual Meeting: 1994